Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: Case report and review of the literature

Dermatology

Volumn 226, Issue 4, 2013, Pages 302-310

  Kolios, Antonios G A ^a   Marques Maggio, Ewerton ^b   Gubler, Christoph ^b   Cozzio, Antonio ^a   Dummer, Reinhard ^a   French, Lars E ^a   Navarini, Alexander A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Alitretinoin; Cutaneous lichen planus; Esophageal lichen planus; Lichen ruber planus; Oral lichen planus

Indexed keywords

ALITRETINOIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; ETRETIN; PIMECROLIMUS; TRIAMCINOLONE ACETONIDE; ANTINEOPLASTIC AGENT; RETINOIC ACID;

ADULT; CASE REPORT; CUTANEOUS LICHEN PLANUS; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; ESOPHAGEAL LICHEN PLANUS; ESOPHAGUS DISEASE; FATIGUE; FEMALE; GASTROSCOPY; HUMAN; LICHEN PLANUS; LOW DRUG DOSE; MIDDLE AGED; MOUTH DISEASE; NAIL DYSTROPHY; ORAL LICHEN PLANUS; PAPULE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SKIN DISEASE; STRIA; TREATMENT DURATION; UNDERWEIGHT; UNSPECIFIED SIDE EFFECT; COMPLICATION; DEGLUTITION DISORDERS; ESOPHAGEAL DISEASES; LICHEN PLANUS, ORAL; PATHOLOGY;

ANTINEOPLASTIC AGENTS; DEGLUTITION DISORDERS; ESOPHAGEAL DISEASES; FEMALE; HUMANS; LICHEN PLANUS; LICHEN PLANUS, ORAL; MIDDLE AGED; TRETINOIN;

EID: 84884279109     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000349980     Document Type: Review

References (135)

1. Brehmer F, Haenssle HA, Schon MP, Emmert S: Response of recalcitrant lichen planus to alitretinoin in 3 patients. J Am Acad Dermatol 2011; 65:e58-e60.
2. Molin S, Ruzicka T: Oral alitretinoin in lichen planus: two case reports. Acta Derm Venereol 2010; 90: 523-524.
3. Pinter A, Patzold S, Kaufmann R: Lichen planus of nails-successful treatment with Alitretinoin. J Dtsch Dermatol Ges 2011; 9: 1033-1034.
4. Hollo P, Szakonyi J, Kiss D, Jokai H, Horvath A, Karpati S: Successful treatment of lichen planus with adalimumab. Acta Derm Venereol 2012; 92: 385-386.
5. Lehman JS, Tollefson MM, Gibson LE: Lichen planus. Int J Dermatol 2009; 48: 682-694.
6. Wolf R, Ruzicka T, Rupec RA: Pleomorphismus des Lichen ruber-klinische Variationsbreite, Pathogenese und Therapie. Akt Dermatol 2010; 36: 180-185.
7. Peretz E, Grunwald MH, Halevy S: Annular plaque on the face. Actinic lichen planus (ALP). Arch Dermatol 1999; 135: 1543-1546.
8. Kim GH, Mikkilineni R: Lichen planus actinicus. Dermatol Online J 2007; 13: 13.
9. Meads SB, Kunishige J, Ramos-Caro FA, Hassanein AM: Lichen planus actinicus. Cutis 2003; 72: 377-381.
10. Zanca A: Lichen planus actinicus. Int J Dermatol 1978; 17: 506-508.
11. Baker H, Almeyda J: Lichen planus actinicus. Br J Dermatol 1970; 82: 426-427.
12. Happle R: Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol 2007; 57: 690-699.
13. Ber Rahman S, Ul Bari A, Mumtaz N: Unilateral Blaschkoid lichen planus involving the entire half of the body, a unique presentation. Dermatol Online J 2007; 13: 36.
14. Sharma R, Maheshwari V, Chandra M: Unilateral multiple linear lichen planus along the lines of Blaschko: a report of two cases. Indian J Dermatol Venereol Leprol 1999; 65: 225-226.
15. Kabbash C, Laude TA, Weinberg JM, Silverberg NB: Lichen planus in the lines of Blaschko. Pediatr Dermatol 2002; 19: 541-545.
16. Turel A, Ozturkcan S, Sahin MT, Turkdogan P: Wolf's isotopic response: a case of zosteriform lichen planus. J Dermatol 2002; 29: 339-342.
17. Mohrenschlager M, Engst R, Hein R, Ring J: Primary manifestation of a zosteriform lichen planus: isotopic response following herpes zoster sine herpete? Br J Dermatol 2008; 158: 1145-1146.
18. Mizukawa Y, Horie C, Yamazaki Y, Shiohara T: Detection of varicella-zoster virus antigens in lesional skin of zosteriform lichen planus but not in that of linear lichen planus. Dermatology 2012; 225: 22-26.
19. Dostrovsky A, Sagher F: Lichen planus in subtropical countries; study of an annular type with inverse localization (uncovered surfaces of the skin). Arch Derm Syphilol 1949; 59: 308-328.
20. Pock L, Jelinkova L, Drlik L, et al: Lichen planus pigmentosus-inversus. J Eur Acad Dermatol Venereol 2001; 15: 452-454.
21. Kashima A, Tajiri A, Yamashita A, Asada Y, Setoyama M: Two Japanese cases of lichen planus pigmentosus-inversus. Int J Dermatol 2007; 46: 740-742.
22. Bennassar A, Mas A, Julia M, Iranzo P, Ferrando J: Annular plaques in the skin folds: 4 cases of lichen planus pigmentosus-inversus (in Spanish). Actas Dermosifiliogr 2009; 100: 602-605.
23. Jung YJ, Lee YH, Lee SY, Lee WS: A case of lichen planus pigmentosus-inversus in a Korean patient. Ann Dermatol 2011; 23: 61-63.
24. Ohshima N, Shirai A, Saito I, Asahina A: Lichen planus pigmentosus-inversus occurring extensively in multiple intertriginous areas. J Dermatol 2012; 39: 412-414.
25. Gaertner E, Elstein W: Lichen planus pigmentosus-inversus: case report and review of an unusual entity. Dermatol Online J 2012; 18: 11.
26. Kim BS, Aum JA, Kim HS, et al: Coexistence of classic lichen planus and lichen planus pigmentosus-inversus: resistant to both tacrolimus and clobetasol propionate ointments. J Eur Acad Dermatol Venereol 2008; 22: 106-107.
27. Requena L, Olivares M, Pique E, Farina MC, Martin L: Annular atrophic lichen planus. Dermatology 1994; 189: 95-98.
28. Lipsker D, Piette JC, Laporte JL, Maunoury L, Frances C: Annular atrophic lichen planus and Sneddon's syndrome. Dermatology 1997; 195: 402-403.
29. Mseddi M, Bouassida S, Marrakchi S, Khemakhem M, Turki H, Zahaf A: Annular atrophic lichen planus. Dermatology 2003; 207: 208-209.
30. Morales-Callaghan A Jr, Martinez G, Aragoneses H, Miranda-Romero A: Annular atrophic lichen planus. J Am Acad Dermatol 2005; 52: 906-908.
31. Ponce-Olivera RM, Tirado-Sanchez A, Montes-de-Oca-Sanchez G, Leon-Dorantes G, Mercadillo-Perez P: Annular atrophic lichen planus. Int J Dermatol 2007; 46: 490-491.
32. Kim JS, Kang MS, Sagong C, Yu HJ: Annular atrophic lichen planus associated with hypertrophic lichen planus. Clin Exp Dermatol 2008; 33: 195-197.
33. Serrao VV, Organ V, Pereira L, Vale E, Correia S: Annular lichen planus in association with Crohn disease. Dermatol Online J 2008; 14: 5.
34. Li B, Li JH, Xiao T, He CD, Gao XH, Chen HD: Annular atrophic lichen planus. Eur J Dermatol 2010; 20: 842-843.
35. Sugashima Y, Yamamoto T: Letter: Annular atrophic lichen planus of the lip. Dermatol Online J 2012; 18: 14.
36. Simpson RC, Littlewood SM, Cooper SM, et al: Real-life experience of managing vulval erosive lichen planus: a case-based review and U.K. multicentre case note audit. Br J Dermatol 2012; 167: 85-91.
37. Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R: Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev 2012; 2: CD008092.
38. Goucha S, Khaled A, Bennani Z, et al: Erosive lichen planus of the soles: effective response to prednisone. Dermatol Ther (Heidelb) 2011; 1: 20-24.
39. Kuramoto N, Kishimoto S, Shibagaki R, Yasuno H: PUVA-induced lichen planus pemphigoides. Br J Dermatol 2000; 142: 509-512.
40. Maoz KB, Brenner S: Lichen planus pemphigoides triggered by narrowband UVB, paracetamol, and ibuprofen, with autoantibodies to 130 kDa antigen. Skinmed 2008; 7: 33-36.
41. Stoebner PE, Michot C, Ligeron C, Durand L, Meynadier J, Meunier L: Simvastatin-induced lichen planus pemphigoides (in French). Ann Dermatol Venereol 2003; 130(2 Pt 1):187-190.
42. Zhu YI, Fitzpatrick JE, Kornfeld BW: Lichen planus pemphigoides associated with ramipril. Int J Dermatol 2006; 45: 1453-1455.
43. Ogg GS, Bhogal BS, Hashimoto T, Coleman R, Barker JN: Ramipril-associated lichen planus pemphigoides. Br J Dermatol 1997; 136: 412-414.
44. Yoon KH, Kim SC, Kang DS, Lee IJ: Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens. Eur J Dermatol 2000; 10: 212-214.
45. Hsu S, Ghohestani RF, Uitto J: Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen). J Am Acad Dermatol 2000; 42(1 Pt 1):136-141.
46. Mignogna MD, Fortuna G, Leuci S, Stasio L, Mezza E, Ruoppo E: Lichen planus pemphigoides, a possible example of epitope spreading. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 837-843.
47. Barnadas MA, Roe E, Dalmau J, Alomar A, Martinez L, Gelpi C: Lichen planus pemphigoides: detection of anti-BP 180 antibodies by ELISA and immunoblotting tests. J Eur Acad Dermatol Venereol 2010; 24: 1360-1361.
48. Cohen DM, Ben-Amitai D, Feinmesser M, Zvulunov A: Childhood lichen planus pemphigoides: a case report and review of the literature. Pediatr Dermatol 2009; 26: 569-574.
49. Harting MS, Hsu S: Lichen planus pemphigoides: a case report and review of the literature. Dermatol Online J 2006; 12: 10.
50. Skaria M, Salomon D, Jaunin F, Friedli A, Saurat JH, Borradori L: IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Dermatology 1999; 199: 253-255.
51. Zillikens D, Caux F, Mascaro JM, et al: Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 1999; 113: 117-121.
52. Romero RW, Nesbitt LT Jr, Reed RJ: Unusual variant of lupus erythematosus or lichen planus. Clinical, histopathologic, and immunofluorescent studies. Arch Dermatol 1977; 113: 741-748.
53. Copeman PW, Schroeter AL, Kierland RR: An unusual variant of lupus erythematosus or lichen planus. Br J Dermatol 1970; 83: 269-272.
54. Nagao K, Chen KR: A case of lupus erythematosus/ lichen planus overlap syndrome. J Dermatol 2006; 33: 187-190.
55. Muller FB, Groth W, Mahrle G: Multiple autoimmune syndrome. Reynolds-syndrome (acral scleroderma, primary biliary cirrhosis, Sjögren syndrome) associated with the lupus erythematosus/lichen planus overlap syndrome (in German). Hautarzt 2004; 55: 465-470.
56. Inaloz HS, Chowdhury MM, Motley RJ: Lupus erythematosus/lichen planus overlap syndrome with scarring alopecia. J Eur Acad Dermatol Venereol 2001; 15: 171-174.
57. Mahler V, Hornstein OP, Meyer S, Albrecht HP, Kiesewetter F: Lupus erythematosus/lichen ruber planus overlap syndrome. cases in a patient sample of the Erlangen University Dermatology Clinic (1894-1995) (in German). Hautarzt 1998; 49: 295-302.
58. Arisawa EA, Almeida JD, Carvalho YR, Cabral LA: Clinicopathological analysis of oral mucous autoimmune disease: a 27-year study. Med Oral Patol Oral Cir Bucal 2008; 13:E94-E97.
59. Altman J, Perry HO: The variations and course of lichen planus. Arch Dermatol 1961; 84: 179-191.
60. Scully C, Beyli M, Ferreiro MC, et al: Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
61. van Tuyll van Serooskerken AM, van Marion AM, de Zwart-Storm E, Frank J, Poblete-Gutierrez P: Lichen planus with bullous manifestation on the lip. Int J Dermatol 2007; 46(suppl 3):25-26.
62. Chatterjee K, Bhattacharya S, Mukherjee CG, Mazumdar A: A retrospective study of oral lichen planus in paediatric population. J Oral Maxillofac Pathol 2012; 16: 363-367.
63. Goldstein AT, Metz A: Vulvar lichen planus. Clin Obstet Gynecol 2005; 48: 818-823.
64. O'Connell TX, Nathan LS, Satmary WA, Goldstein AT: Non-neoplastic epithelial disorders of the vulva. Am Fam Physician 2008; 77: 321-326.
65. Setterfield JF, Neill S, Shirlaw PJ, et al: The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1∗ 0201 allele. J Am Acad Dermatol 2006; 55: 98-113.
66. Al-Shihabi BM, Jackson JM: Dysphagia due to pharyngeal and oesophageal lichen planus. J Laryngol Otol 1982; 96: 567-571.
67. Quispel R, van Boxel OS, Schipper ME, et al: High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy 2009; 41: 187-193.
68. Katzka DA, Smyrk TC, Bruce AJ, Romero Y, Alexander JA, Murray JA: Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol 2010; 8: 777-782.
69. Fox LP, Lightdale CJ, Grossman ME: Lichen planus of the esophagus: what dermatologists need to know. J Am Acad Dermatol 2011; 65: 175-183.
70. Yoon RY, Sullivan SN: Esophageal lichen planus. Gastrointest Endosc 1990; 36: 617-619.
71. Chryssostalis A, Gaudric M, Terris B, Coriat R, Prat F, Chaussade S: Esophageal lichen planus: a series of eight cases including a patient with esophageal verrucous carcinoma. A case series. Endoscopy 2008; 40: 764-768.
72. Abraham SC, Ravich WJ, Anhalt GJ, Yardley JH, Wu TT: Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol 2000; 24: 1678-1682.
73. Williams TR, Haider-Shah H: Diffuse esophageal stricture secondary to esophageal lichen planus. Abdom Imaging 2005; 30: 355-357.
74. Sanli H, Cetinkaya H, Tursen U, Kaya M, Kuzu I, Gurler A: Upper gastrointestinal findings in oral lichen planus. Turk J Gastroenterol 2002; 13: 31-34.
75. Ronkainen J, Aro P, Storskrubb T, et al: High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-285.
76. Chandan VS, Murray JA, Abraham SC: Esophageal lichen planus. Arch Pathol Lab Med 2008; 132: 1026-1029.
77. Valdes F, Caparrini A, Calzada JM: Lichen planus with esophageal involvement (in Spanish. Actas Dermosifiliogr 2007; 98: 361-364.
78. Harewood GC, Murray JA, Cameron AJ: Esophageal lichen planus: the Mayo Clinic experience. Dis Esophagus 1999; 12: 309-311.
79. Van Maercke P, Gunther M, Groth W, Gheorghiu T, Habermann U: Lichen ruber mucosae with esophageal involvement. Endoscopy 1988; 20: 158-160.
80. Schiavino D, Murzilli F, Forti G, Chiarelli C, Altomonte L, Magaro M: Mucocutaneous lichen planus with esophageal involvement. A clinical case (in Italian). Minerva Med 1992; 83: 73-76.
81. Bobadilla J, van der Hulst RW, ten Kate FJ, Tytgat GN: Esophageal lichen planus. Gastrointest Endosc 1999; 50: 268-271.
82. Madhusudhan KS, Sharma R: Esophageal lichen planus: a case report and review of literature. Indian J Dermatol 2008; 53: 26-27.
83. Keate RF, Williams JW, Connolly SM: Lichen planus esophagitis: report of three patients treated with oral tacrolimus or intraesophageal corticosteroid injections or both. Dis Esophagus 2003; 16: 47-53.
84. Parmentier L, Bron BA, Prins C, Samson J, Masouye I, Borradori L: Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody. Arch Dermatol 2008; 144: 1427-1430.
85. Donnellan F, Swan MP, May GR, Kandel G, Marcon NE, Kortan PP: Fluticasone propionate for treatment of esophageal lichen planus. A case series. Dis Esophagus 2011; 24: 211-214.
86. Chaklader M, Morris-Larkin C, Gulliver W, McGrath J: Cyclosporine in the management of esophageal lichen planus. Can J Gastroenterol 2009; 23: 686-688.
87. Izol B, Karabulut AA, Biyikoglu I, Gonultas M, Eksioglu M: Investigation of upper gastrointestinal tract involvement and H. pylori presence in lichen planus: a case-controlled study with endoscopic and histopathological findings. Int J Dermatol 2010; 49: 1121-1126.
88. Tunca A, Calikoglu E, Aktas D, Safak N, Ustun H: Oral lichen planus: an unusual cause of facial and abducens nerve paralysis associated with conjunctival and oesophageal involvement. J Eur Acad Dermatol Venereol 2004; 18: 630-633.
89. Menges M, Hohloch K, Pueschel W, Stallmach A: Lichen planus with oesophageal involvement. A case report and review of the literature. Digestion 2002; 65: 184-189.
90. Schwartz MP, Sigurdsson V, Vreuls W, Lubbert PH, Smout AJ: Two siblings with lichen planus and squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol 2006; 18: 1111-1115.
91. Aubert A, Hammel P, Perniceni T, et al: Epidermoid carcinoma complicating esophageal lichen planus without cutaneous or oral involvement. Gastrointest Endosc 2011; 74: 221-223.
92. Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR: A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol 2007; 57: 47-53.
93. Mehregan DA, Van Hale HM, Muller SA: Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol 1992; 27(6 Pt 1):935-942.
94. Friedl TK, Flaig MJ, Ruzicka T, Rupec RA: Verrucous squamous cell carcinoma complicating hypertrophic lichen planus. Three case reports and review of the literature (in German). Hautarzt 2011; 62: 40-45.
95. Ardabili M, Gambichler T, Rotterdam S, Altmeyer P, Hoffmann K, Stucker M: Metastatic cutaneous squamous cell carcinoma arising from a previous area of chronic hypertrophic lichen planus. Dermatol Online J 2003; 9: 10.
96. Sigurgeirsson B, Lindelof B: Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol 1991; 127: 1684-1688.
97. Pindborg JJ, Wahi PN: Histological Typing of Cancer and Precancer of the Oral Mucosa. Berlin/Heidelberg, Springer, 1997.
98. Silverman S Jr, Gorsky M, Lozada-Nur F, Giannotti K: A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665-670.
99. Silverman S Jr, Gorsky M, Lozada-Nur F: A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985; 60: 30-34.
100. Eisen D: The clinical manifestations and treatment of oral lichen planus. Dermatol Clin 2003; 21: 79-89.
101. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K: Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 164-178.
102. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E: Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004; 40: 120-130.
103. Franck JM, Young AW Jr: Squamous cell carcinoma in situ arising within lichen planus of the vulva. Dermatol Surg 1995; 21: 890-894.
104. Dwyer CM, Kerr RE, Millan DW: Squamous carcinoma following lichen planus of the vulva. Clin Exp Dermatol 1995; 20: 171-172.
105. Leal-Khouri S, Hruza GJ: Squamous cell carcinoma developing within lichen planus of the penis. Treatment with Mohs micrographic surgery. J Dermatol Surg Oncol 1994; 20: 272-276.
106. Worheide J, Bonsmann G, Kolde G, Hamm H: Squamous epithelial carcinoma at the site of lichen ruber hypertrophicus of the glans penis (in German). Hautarzt 1991; 42: 112-115.
107. Gupta R, Bansal B, Singh S, Yadav I, Gupta K, Kudesia M: Lichen planus of uterine cervix-the first report of a novel site of occurrence: a case report. Cases J 2009; 2: 9306.
108. Fundaro S, Spallanzani A, Ricchi E, et al: Squamous-cell carcinoma developing within anal lichen planus: report of a case. Dis Colon Rectum 1998; 41: 111-114.
109. Sharma R, Maheshwari V: Childhood lichen planus: a report of fifty cases. Pediatr Dermatol 1999; 16: 345-348.
110. Handa S, Sahoo B: Childhood lichen planus: a study of 87 cases. Int J Dermatol 2002; 41: 423-427.
111. Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L: Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol 2012; 26: 1415-1419.
112. Ohno S, Tateishi Y, Tatemoto Y, Morishita K, Sasabe E, Yamamoto T: Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus. J Dermatol 2011; 38: 335-344.
113. Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Srinivasan M: Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol 2012; 57: 495-502.
114. Sugerman PB, Savage NW, Walsh LJ, et al: The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13: 350-365.
115. Matthews JB, Scully CM, Potts AJ: Oral lichen planus: an immunoperoxidase study using monoclonal antibodies to lymphocyte subsets. Br J Dermatol 1984; 111: 587-595.
116. Fonseca-Silva T, Oliveira MV, Fraga CA, et al: DNMT3B (C46359T) polymorphisms and immunoexpression of DNMT3b and DNMT1 proteins in oral lichen planus. Pathobiology 2012; 79: 18-23.
117. Arao TC, Guimaraes AL, de Paula AM, Gomes CC, Gomez RS: Increased miRNA-146a and miRNA-155 expressions in oral lichen planus. Arch Dermatol Res 2012; 304: 371-375.
118. Pauley KM, Cha S, Chan EK: MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009; 32: 189-194.
119. Coppede F, Zitarosa MT, Migheli F, et al: DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr Alzheimer Res 2012; 9: 550-554.
120. Banerjee A, Schambach F, DeJong CS, Hammond SM, Reiner SL: Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol 2010; 40: 225-231.
121. Tang Y, Luo X, Cui H, et al: MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-1075.
122. Erdem MT, Gulec AI, Kiziltunc A, Yildirim A, Atasoy M: Increased serum levels of tumor necrosis factor alpha in lichen planus. Dermatology 2003; 207: 367-370.
123. Sharma R, Sircar K, Singh S, Rastogi V: Role of mast cells in pathogenesis of oral lichen planus. J Oral Maxillofac Pathol 2011; 15: 267-271.
124. Zhao ZZ, Savage NW, Sugerman PB, Walsh LJ: Mast cell/T cell interactions in oral lichen planus. J Oral Pathol Med 2002; 31: 189-195.
125. Rhodus NL, Cheng B, Ondrey F: Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm 2007; 2007: 19854.
126. Shaker O, Hassan AS: Possible role of interleukin-17 in the pathogenesis of lichen planus. Br J Dermatol 2012; 166: 1367-1368.
127. Maender JL, Krishnan RS, Angel TA, Hsu S: Complete resolution of generalized lichen planus after treatment with thalidomide. J Drugs Dermatol 2005; 4: 86-88.
128. Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF: Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Br J Dermatol 2012; 167: 36-43.
129. Yarom N: Etanercept for the management of oral lichen planus. Am J Clin Dermatol 2007; 8: 121.
130. Irla N, Schneiter T, Haneke E, Yawalkar N: Nail lichen planus: successful treatment with etanercept. Case Rep Dermatol 2010; 2: 173-176.
131. Chao TJ: Adalimumab in the management of cutaneous and oral lichen planus. Cutis 2009; 84: 325-328.
132. Lodi G, Carrozzo M, Furness S, Thongprasom K: Interventions for treating oral lichen planus: a systematic review. Br J Dermatol 2012; 166: 938-947.
133. Keenan AV, Ferraiolo D: Insufficient evidence for effectiveness of any treatment for oral lichen planus. Evid Based Dent 2011; 12: 85-86.
134. Calabrese C, Fabbri A, Benni M, et al: Squamous cell carcinoma arising in esophageal lichen planus. Gastrointest Endosc 2003; 57: 596-599.
135. Ruzicka T, Lynde CW, Jemec GB, et al: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-817.